Regulation of the mammalian heart function by nitric oxide

被引:94
作者
Massion, PB [1 ]
Pelat, M [1 ]
Belge, C [1 ]
Balligand, JL [1 ]
机构
[1] Catholic Univ Louvain, Unit Pharmacol & Therapeut, B-1200 Brussels, Belgium
来源
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY | 2005年 / 142卷 / 02期
关键词
nitric oxide; contractility; cardiac; autonomic; catecholamines;
D O I
10.1016/j.cbpb.2005.05.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian heart expresses all three isoforms of nitric oxide synthases (NOS) in diverse cell types of the myocardium. Despite their apparent promiscuity, the NOS isoforms support specific signaling because of their subcellular compartmentation with colocalized effectors and limited diffusibility of NO in muscle cells. eNOS and nNOS sustain normal EC coupling and contribute to the early and late phases of the Frank-Starling mechanism of the heart. They also attenuate the beta1-/beta2-adrenergic increase in inotropy and chronotropy, and reinforce the pre- and post-synaptic vagal control of cardiac contraction. By doing so, the NOS protect the heart against excessive stimulation by catecholamines, Just as an "endogenous beta-blocker". In the ischemic and failing myocardium, induced iNOS further reinforces this effect, as does eNOS coupled to overexpressed beta3-adrenoceptors. nNOS expression also increases in the aging and infarcted heart, but its role (compensatory or deleterious) is less clear. In addition to their direct regulation of contractility, the NOS modulate oxygen consumption, substrate utilization, sensitivity to apoptosis, hypertrophy and regenerative potential, all of which illustrate the pleiotropic effects of this radical on the cardiac cell biology. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [11] Biochemistry of mitochondrial nitric-oxide synthase
    Elfering, SL
    Sarkela, TM
    Giulivi, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) : 38079 - 38086
  • [12] The endothelial nitric-oxide synthase-caveolin regulatory cycle
    Feron, O
    Saldana, F
    Michel, JB
    Michel, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) : 3125 - 3128
  • [13] Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes
    Feron, O
    Smith, TW
    Michel, T
    Kelly, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) : 17744 - 17748
  • [14] Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
    Feron, O
    Dessy, C
    Moniotte, S
    Desager, JP
    Balligand, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) : 897 - 905
  • [15] Myoglobin:: A scavenger of bioactive NO
    Flögel, U
    Merx, MW
    Gödecke, A
    Decking, UKM
    Schrader, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) : 735 - 740
  • [16] Förstermann U, 1998, FASEB J, V12, P773
  • [17] The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
    Gauthier, C
    Leblais, V
    Kobzik, L
    Trochu, JN
    Khandoudi, N
    Bril, A
    Balligand, JL
    Le Marec, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) : 1377 - 1384
  • [18] SUPEROXIDE ANION IS INVOLVED IN THE BREAKDOWN OF ENDOTHELIUM-DERIVED VASCULAR RELAXING FACTOR
    GRYGLEWSKI, RJ
    PALMER, RMJ
    MONCADA, S
    [J]. NATURE, 1986, 320 (6061) : 454 - 456
  • [19] NO/redox disequilibrium in the failing heart and cardiovascular system
    Hare, JM
    Stamler, JS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (03) : 509 - 517
  • [20] Spatial confinement of isoforms of cardiac nitric-oxide synthase: unravelling the complexities of nitric oxide's cardiobiology
    Hare, JM
    [J]. LANCET, 2004, 363 (9418) : 1338 - 1339